• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha.

作者信息

Bacher U, Hochhaus A, Berger U, Hiddemann W, Hehlmann R, Haferlach T, Schoch C

出版信息

Leukemia. 2005 Mar;19(3):460-3. doi: 10.1038/sj.leu.2403607.

DOI:10.1038/sj.leu.2403607
PMID:15625554
Abstract
摘要

相似文献

1
Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha.
Leukemia. 2005 Mar;19(3):460-3. doi: 10.1038/sj.leu.2403607.
2
Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with Imatinib.
Leukemia. 2003 Feb;17(2):465-7. doi: 10.1038/sj.leu.2402791.
3
[Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].[甲磺酸伊马替尼治疗费城染色体阳性慢性髓性白血病患者后异常费城染色体阴性细胞的克隆进化]
Zhonghua Xue Ye Xue Za Zhi. 2005 Jan;26(1):23-6.
4
Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8.
Leukemia. 2002 Jul;16(7):1390-3. doi: 10.1038/sj.leu.2402634.
5
Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate.对甲磺酸伊马替尼完全细胞遗传学反应的慢性髓性白血病患者的克隆性细胞遗传学异常
Haematologica. 2005 Apr;90(4):556-8.
6
Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.伊马替尼治疗费城染色体阳性慢性髓性白血病期间费城染色体阴性细胞中克隆性染色体异常的34例患者报告
Leukemia. 2004 Aug;18(8):1340-6. doi: 10.1038/sj.leu.2403399.
7
Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.甲磺酸伊马替尼治疗可改善新诊断的慢性期费城染色体阳性慢性髓性白血病患者的生存率：与历史数据比较。
Cancer. 2003 Dec 15;98(12):2636-42. doi: 10.1002/cncr.11831.
8
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.慢性髓性白血病患者伊马替尼治疗后出现的费城染色体阴性克隆性造血：9例报告及预测因素分析
Cancer Genet Cytogenet. 2006 Oct 1;170(1):16-23. doi: 10.1016/j.cancergencyto.2006.04.012.
9
Duplication of the Ph-chromosome as a possible mechanism of resistance to imatinib mesylate in patients with chronic myelogenous leukemia.作为慢性粒细胞白血病患者对甲磺酸伊马替尼耐药的一种可能机制，费城染色体的复制
Cancer Genet Cytogenet. 2005 Dec;163(2):189-90. doi: 10.1016/j.cancergencyto.2005.05.004.
10
Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.在慢性期费城染色体阳性慢性髓性白血病患者接受甲磺酸伊马替尼治疗期间出现的费城染色体阴性中期的染色体异常。
Cancer. 2003 Nov 1;98(9):1905-11. doi: 10.1002/cncr.11729.

引用本文的文献

1
An interesting case of chronic myeloid leukemia with twists and turns.一例曲折多变的慢性髓系白血病有趣病例。
Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S385-S388. doi: 10.1016/j.htct.2023.02.001. Epub 2023 Mar 7.
2
The Impact of Cytogenetic Aberrations in the Clonal Evolution of Chronic Myeloid Leukemia: A Single-Center Experience Among 450 Turkish Patients (Cohort Study).细胞遗传学异常在慢性髓性白血病克隆进化中的影响：450 例土耳其患者的单中心经验（队列研究）。
Turk J Haematol. 2022 Dec 1;39(4):237-244. doi: 10.4274/tjh.galenos.2022.2022.0045. Epub 2022 Oct 6.
3
[Philadelphia chromosome-negative myeloid neoplasms in patients with Philadelphia chromosome-positive chronic myeloid leukemia during tyrosine kinase inhibtor-therapy].
[酪氨酸激酶抑制剂治疗期间费城染色体阳性慢性髓性白血病患者中的费城染色体阴性髓系肿瘤]
Zhonghua Xue Ye Xue Za Zhi. 2019 Jul 14;40(7):547-553. doi: 10.3760/cma.j.issn.0253-2727.2019.07.003.
4
A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML.对慢性粒细胞白血病患者中出现的费城染色体阴性急性髓系白血病的基因组分析。
Blood Cancer J. 2016 Apr 8;6(4):e413. doi: 10.1038/bcj.2016.18.
5
Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report.尼洛替尼治疗期间慢性粒细胞白血病患者出现短暂性7号染色体单体：一例报告
Clin Case Rep. 2016 Feb 8;4(3):282-6. doi: 10.1002/ccr3.506. eCollection 2016 Mar.
6
Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis.慢性粒细胞白血病中涉及11q23位点的染色体重排：一种罕见现象，常与疾病进展和预后不良相关。
J Hematol Oncol. 2015 Apr 8;8:32. doi: 10.1186/s13045-015-0128-2.
7
Coexisting with clonal evolution and BCR-ABL mutant in CML patients treated with second-generation tyrosine kinase inhibitors predict the discrepancy of in vitro drug sensitivity.在接受第二代酪氨酸激酶抑制剂治疗的 CML 患者中，与克隆进化和 BCR-ABL 突变共存可预测体外药物敏感性的差异。
Cancer Res Treat. 2010 Mar;42(1):37-41. doi: 10.4143/crt.2010.42.1.37. Epub 2010 Mar 31.
8
t(5;6;12) associated with resistance to imatinib mesylate in chronic myeloid leukemia.与慢性髓性白血病中对甲磺酸伊马替尼耐药相关的t(5;6;12)
Int J Hematol. 2009 May;89(4):508-512. doi: 10.1007/s12185-009-0275-8. Epub 2009 Mar 26.
9
Successful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sections.使用存档骨髓涂片和石蜡包埋组织切片成功应用基于玻片的直接检测序贯表型/基因型分析。
J Mol Diagn. 2007 Nov;9(5):589-97. doi: 10.2353/jmoldx.2007.070050.
10
[Hematological side effects of tyrosine kinase inhibition using imatinib].[伊马替尼抑制酪氨酸激酶的血液学副作用]
Pathologe. 2006 Feb;27(1):40-6. doi: 10.1007/s00292-005-0806-x.